Roche (ROG SW) CEO guarantees they will not miss guidance as historically they have never missed, always the opportunity to overperform, Bloomberg TV
Importance
Level 1
- Signed an agreement on new products with the US government.
- GLP-1 Phase II trial had "phenomenal results", believe the product can significantly beat peers. Not concerned about getting to the market too late, are only "scratching the surface".
- AI is being used across the business.
#SWITZERLAND#ROCHE HOLDING AG#EQUITIES#EU SESSION#PHARMACEUTICALS#PHARMACEUTICALS (GROUP)#PHARMACEUTICALS, BIOTECHNOLOGY & LIFE SCIENCES#SWISS MARKET INDEX#ROG#SMI